Rats develop cannabis-seeking behaviour
A recent study in which rats could self-administer cannabis vapor may provide a useful research model for humans.
Kyle Turley advocates cannabis as ‘cure’ for COVID-19, even after warnings from feds
Kyle Turley believes cannabis can cure COVID-19.
New Medicinal Cannabis Rules Launch in New Zealand
Patients could face fewer barriers to access medicinal cannabis products in New Zealand as new rules launch today. The new rules should make it easier for doctors to prescribe products and for cultivator and manufacturer licenses to be granted.
Jameson Berkow: COVID-19 made cannabis ‘essential,’ but governments aren’t treating the industry that way
There is unlikely to be any progress unless governments start treating their legal cannabis sectors as essential, as right now, that designation appears to provide none of the expected benefits.
After 4-year delay, DEA will review dozens of requests to grow marijuana for research
After nearly 4 years of what some researchers saw as foot dragging, the Drug Enforcement Administration (DEA) has announced it will evaluate 37 applications to grow marijuana for medical research and proposed new rules for the prospective growers that outline how the cannabis-growing program would work.
Military Veterans And Disabled People Given Free Weed During Lockdown
In Michigan, marijuana sales have been declared an essential industry, meaning cannabis dispensaries have been allowed to stay open for business. But in Sheridan, Montcalm County, the green stuff is being given away for free to anyone who can prove they served in the military or were on Social Security disability.
Pharmacology of Medical Cannabis
The Cannabis plant has been used for many of years as a medicinal agent in the relief of pain and seizures. It contains approximately 540 natural compounds including more than 100 that have been identified as phytocannabinoids due to their shared chemical structure. The legalization of cannabis for medicinal purposes and for recreational use in some regions will allow for much needed research on the pharmacokinetics and pharmocology of medical cannabis. This brief review focuses on the use of cannabis as a medicinal agent in the treatment of pain, epilepsy and neurodegenerative diseases. Despite the paucity of information, attention is paid to the mechanisms by which medical cannabis may act to relieve pain and seizures.
[Medical cannabis: the opportunity versus the temptation]
The cannabis plant has been known to humanity for centuries as a remedy for pain, diarrhea, and inflammation. Current research has shown cannabis to be a useful remedy for many diseases, including multiple sclerosis, dystonia, and chronic pain. Cannabinoids are used to improve food intake in anorexia of AIDS patients and to prevent vomiting due to cancer chemotherapy. In inflammatory conditions cannabinoids improve pain in rheumatoid arthritis and pain and diarrhea in Crohn’s disease.
Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases
The endocannabinoid system is a complex and nearly ubiquitous network of endogenous ligands, enzymes, and receptors that can also be stimulated by exogenous compounds such as those derived from the marijuana plant, Cannabis sativa. Recent data have shown that the endocannabinoid system is fully functional in the skin and is responsible for maintaining many aspects of skin homeostasis, such as proliferation, differentiation, and release of inflammatory mediators.
Oncology Clinicians and the Minnesota Medical Cannabis Program: A Survey on Medical Cannabis Practice Patterns, Barriers to Enrollment, and Educational Needs
Medical cannabis has been available in the State of Minnesota since July 2015 through the Minnesota Medical Cannabis Program (MMCP). Our study aimed to delineate oncology providers’ views on medical cannabis, identify barriers to patient enrollment, and assess clinicians’ interest in a clinical trial of medical cannabis in patients with stage IV cancer. Although support for cannabis use in the cancer setting is growing, significant barriers remain. This study illustrates a clear need to give clinicians both data and education to guide their discussions about the benefits, risks, and cost considerations of using medical cannabis for cancer-related symptoms.